Carisma Therapeutics Inc. Cash Flow-to-Debt Ratio
Carisma Therapeutics Inc. cash flow-to-debt ratio. Carisma Therapeutics Inc. (CARM) has a Cash Flow-to-Debt Ratio of 0.26x as of September 2025, meaning its operating cash flow of $1.91 Million could theoretically repay 0% of its total liabilities ($7.42 Million) in one year. Check CARM cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Carisma Therapeutics Inc. (2011–2024)
Cash flow-to-debt ratio of Carisma Therapeutics Inc. from 2011 to 2024. Historical debt coverage capacity for Carisma Therapeutics Inc. across 14 annual periods. Check cash flow reinvestment rate of Carisma Therapeutics Inc. to assess the company's total reinvestment commitment from operating cash flow.
Carisma Therapeutics Inc. Cash Flow-to-Debt Ratio by Year (2011–2024)
Carisma Therapeutics Inc. cash flow-to-debt ratio by year from 2011 to 2024. Year-by-year debt coverage analysis for Carisma Therapeutics Inc.. For the full cash flow conversion analysis, see Carisma Therapeutics Inc. (CARM) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.03x | $-59.92 Million | $58.37 Million | ▲ +20.3% |
| 2023 | -1.29x | $-81.18 Million | $63.02 Million | ▼ -3557.3% |
| 2022 | -0.04x | $-7.57 Million | $214.82 Million | ▲ +86.7% |
| 2021 | -0.26x | $-37.33 Million | $140.89 Million | ▼ -93.9% |
| 2020 | -0.14x | $-27.01 Million | $197.68 Million | ▲ +48.6% |
| 2019 | -0.27x | $-37.52 Million | $141.06 Million | ▲ +21.5% |
| 2018 | -0.34x | $-22.83 Million | $67.35 Million | ▼ -8.9% |
| 2017 | -0.31x | $-17.77 Million | $57.06 Million | ▼ -876.8% |
| 2016 | 0.04x | $2.62 Million | $65.42 Million | ▲ +102.1% |
| 2015 | -1.93x | $-34.53 Million | $17.88 Million | ▼ -19.7% |
| 2014 | -1.61x | $-29.31 Million | $18.17 Million | ▼ -6.3% |
| 2013 | -1.52x | $-13.49 Million | $8.89 Million | ▲ +70.1% |
| 2012 | -5.07x | $-19.09 Million | $3.76 Million | ▼ -31.2% |
| 2011 | -3.87x | $-10.87 Million | $2.81 Million | — |